Latuda Cliff & Bad Resp Sales = lay offs

Discussion in 'Sunovion' started by anonymous, Nov 15, 2017 at 6:56 PM.

  1. anonymous

    anonymous Guest

    This company is like the Titantic. It is slowly sinking and anyone left on the boat will drown. The leadership team is so clueless and several need retire already. One person in particular does nothing but walk around all day chatting and everyone is so fake to him and could careless about his old values that make no sense and he is a huge pain in the ass.
     

  2. anonymous

    anonymous Guest


    It's happening for sure....The respiratory team is not even close to closing the gap to match what is needed to cover for the pending losses as Latuda going off....Huge disappointment thus far, completely mismanaged starting with the hiring of a Flex sales force from PDI....Think about it, they hired flextime contract reps to launch a new product in a crowed space with very limited coverage...what brain child thought that one up or why in the world did we sign off on it....I heard it cost us over $40 million for that project. They just "restructured" it to now be full time reps, but they kept many of the people that were flew time, hourly employees so you can only imagine how much impact they will be having. We have changed strategies more then some change their underwear....trying to get our PUDs to write..The managed access team has not been able to get very much accomplished and wont now until 2019...yes you heard that 2019....ask your manager. So at the end of march when the redemption cards are no longer counted...watch the weeklies plunge. It has been a great run, but time to abandon ship before it goes down.....
     
  3. anonymous

    anonymous Guest

    Had a meeting this morning about the transition planning. It looks like lay offs will come sooner than originally thought. With resp products down so low, there is no way to make up the numbers. I think everyone will be shocked on the number of people both in HQ and field. It will be a Skelton crew by this time next year. Get ready to do five more jobs, if you make it.
     
  4. anonymous

    anonymous Guest


    It was a good ride while it lasted. I guess we all knew it would happen sooner or later with this crappy leadership team making decisions. The whole environment is so negative now.
     
  5. anonymous

    anonymous Guest

    I don't think there are many of us who think there won't be a sizable lay off. We are not idiots. We will be losing a drug that is making $1.28 BILLION dollars a year. Soon that 1.28 billion will go down to less than 25 million within a month after losing patent. The new respritory drugs will be doing like 41 million, Brovana will be chugging along at like 210 million, Aptiom will be doing about 140 million. That means we will be having to find a way to cover $800 million in lost sales. That means major layoffs. Like over 50% lay offs. News flash, we know this!!! That is why we are just working about 15 hours a week and waiting to get our severance packages. Been a fun run. I've been here just short of 11 years. I'm going to do what the managed markets guys do. Work about 10 to 15 hours a week until the end.
     
  6. anonymous

    anonymous Guest

    Dilip will fix it.
     
  7. anonymous

    anonymous Guest

    My contract was just renewed for two years. Very Excited !
     
  8. anonymous

    anonymous Guest

    As someone that works in the managed markets group I can say without any hesitation that you are full of crap! Nobody in my group works 10-15 hours a week! Get your facts straight. Normal work week is 8-10 hours with lunch and dinner espensed is typical. Hope that helps
     
  9. anonymous

    anonymous Guest

    Was probably including flight time as well. It’s a long day to fly in to somewhere, have a 15 min pointless meeting where you accomplish nothing, grab lunch and fly back home.
     
  10. anonymous

    anonymous Guest

    Wow! The truth hurts Managed Markets!
     
  11. anonymous

    anonymous Guest

    Not true, we collect airline frequent flyer miles sitting in a first class seat. These frequent flyer miles gives us free trips for our families. This is a major accomplishment we are all proud of.
     
  12. anonymous

    anonymous Guest

    "Truth hurts"? Nonsense, I'm proud that I'm finally milking it until the patent expiration of Latuda. Get ready folks. The cuts will be big and the cuts will be deep. What did you think was going to happen when we are on the verge of losing a product that makes up 64% of our sales? We could combing all the drugs we recently launched and assume all our investigational products are approved and have great launches and all that will plug a 1.5 billion dollar hole in our sales with maybe 350 million. Remember what happened to the respiratory sales teams and the lunesta team. All were let go months before patent expiration. I'm thinking we'll have a sit by the phone day in early March just before the end of the fiscal year.
     
  13. anonymous

    anonymous Guest

    The sands of time are in motion. ‍♂️
     
  14. anonymous

    anonymous Guest

    ‍♂️‍♂️‍♂️‍♂️‍♂️‍♂️‍♂️‍♂️
     
  15. anonymous

    anonymous Guest

    It is going to be a bloodbath. You can't pay 110k+ salaries to resp reps who aren't generating any revenues. Most of the sales volume across the nation is free vouchers.
     
  16. anonymous

    anonymous Guest

    It is scary that people post on here nothing is going to change and they are keeping everyone. Are people really that stupid and clueless? Well, they work at Sunovion, so maybe.
     
  17. anonymous

    anonymous Guest

    The end is near. It is a very sad situation when the respiratory division is struggling to make goal by issuing 30 day vouchers. Focusing on urgent care clinics is technically selling off label. Those clinics treat "accute bronchitis ". If mgmt continues to direct a focus in this area... it can be considered a corporate initiative to sell for off label indications. Who was the genius that decided to acquire those "me too" products?? They can't even give it away.
     
  18. anonymous

    anonymous Guest

    Now that Latuda patent has been extended to 2014 I bet the OP on this thread may want to change their "sky is falling" declaration.
     
  19. anonymous

    anonymous Guest

    You twit. The Latuda patent has been extended to 2024 (not 2014) and that's only if you believe what upper management is telling us. We will have to wait and see what happens in court and I think it is less likely for Latuda to keep it's exclusivity through 2024 than management is claiming. I hope I'm wrong, but I don't think I am.
     
  20. anonymous

    anonymous Guest

    Who's the twit now? Twit.